BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22366443)

  • 1. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.
    Brockton NT; Klimowicz AC; Bose P; Petrillo SK; Konno M; Rudmik L; Dean M; Nakoneshny SC; Matthews TW; Chandarana S; Lau HY; Magliocco AM; Dort JC
    Oral Oncol; 2012 Jul; 48(7):615-22. PubMed ID: 22366443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors.
    Brockton N; Dort J; Lau H; Hao D; Brar S; Klimowicz A; Petrillo S; Diaz R; Doll C; Magliocco A
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):249-57. PubMed ID: 21300470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.
    Klimowicz AC; Bose P; Petrillo SK; Magliocco AM; Dort JC; Brockton NT
    Br J Cancer; 2013 Oct; 109(7):1859-66. PubMed ID: 24008660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
    Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
    J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.
    Yang JS; Lin CW; Chuang CY; Su SC; Lin SH; Yang SF
    Tumour Biol; 2015 Dec; 36(12):9517-24. PubMed ID: 26130414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
    Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
    Histopathology; 2014 Jun; 64(7):921-34. PubMed ID: 24354963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
    Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
    J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
    Zhang BY; Thompson RH; Lohse CM; Dronca RS; Cheville JC; Kwon ED; Leibovich BC
    BJU Int; 2013 Jun; 111(7):1046-53. PubMed ID: 23551810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
    Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
    Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
    Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
    Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
    Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
    Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
    Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
    Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Bolte K; Bache M; Kappler M; Schubert J; Taubert H; Bilkenroth U
    J Oral Pathol Med; 2010 Apr; 39(4):313-7. PubMed ID: 19780905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET).
    Choueiri TK; Cheng S; Qu AQ; Pastorek J; Atkins MB; Signoretti S
    Urol Oncol; 2013 Nov; 31(8):1788-93. PubMed ID: 23141780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
    Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
    Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
    Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
    Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.